NAHL Group
NAH · AIM · Industrial Goods and Services · mcap £18m · 44.6p
NAHL runs National Accident Law, which handles personal injury claims for consumers, and Bush & Co, which provides case management and expert witness services in critical care. It also owned Searches UK, a small property searches business, now sold.
| Date | Type | Announcement | Day |
|---|---|---|---|
| 08 Oct 26 | Completion of the sale of Searches UK Limited
Completed sale of non-core subsidiary Searches UK Limited for £1,234,000 on cash and debt-free basis. |
+1.6% | |
|
Enterprise value £1,234,000
|
|||
| 30 Sep 26 | Holding | Holding(s) in Company | |
| 30 Sep 26 | Results | Half-year Results
H1 2026 revenue grew 5% to £18.3m and profit before tax increased 31% to £2.3m with strong cash generation. |
+7.2% |
|
in line with management's expectations expectations Revenue £18.3m (£17.5m)Underlying operating profit £3.4m (£3.0m)Profit before tax £2.3m (£1.8m)Basic EPS from continuing operations 3.5p (2.7p)Cash from operations £3.6m (£2.8m)Net debt £1.1m (£3.2m)
|
|||
| 28 Sep 26 | Settlement of Contract Dispute
NAHL settles long-standing contract dispute, receiving £1.85m settlement by 15 October 2026. |
+3.7% | |
|
Settlement amount £1.85m
|
|||
| 24 Sep 26 | Holding | Holding(s) in Company | |
| 23 Sep 26 | Notice of Interim Results & Investor Presentation
NAHL Group to announce interim results for half year ended 30 June 2026 on 30 September 2026. |
+2.8% | |
| 28 Aug 26 | Holding | Holding(s) in Company | |
| 27 Aug 26 | Proposed sale of Searches UK Limited
NAHL agrees to sell Searches UK Limited to TM Group for £1.234m enterprise value. |
+5.4% | |
|
Enterprise value £1,234,000Net cash proceeds to Group (estimated) £1,122,000Transaction costs (estimated) £75,000Searches UK FY2025 revenues £3,343,000Searches UK FY2025 EBITDA £363,000EV/Adjusted EBITDA multiple 5.25x
|
|||
| 22 Jul 26 | Trading update | Half Year Trading Update
H1 2026 revenues 3% ahead at £19.7m with underlying operating profit up 8% to £3.4m and net debt down 68%. |
−1.9% |
|
in line with management expectations expectations Revenue £19.7m (£19.1m)Underlying operating profit £3.4m (£3.2m)Free cash flow £2.1m (£1.5m)Net debt £1.0m (£3.2m)Consumer Legal Services revenue £11.3m (£11.0m)Critical Care revenue £8.5m (£8.2m)
|
|||
| 25 Jun 26 | Routine | Result of AGM | |
| 25 Jun 26 | AGM Statement
Chair confirms positive trading momentum continues into Q2 2026; full year guidance unchanged. |
−0.3% | |
|
in line expectations |
|||
| 01 Jun 26 | Holding | Holding(s) in Company | |
| 29 May 26 | Routine | Posting of Annual Report and Notice of AGM | |
| 29 May 26 | Routine | Total Voting Rights | |
| 26 May 26 | Holding | Holding(s) in Company | |
| 19 May 26 | Exercise of Share Options and Total Voting Rights
237,000 new ordinary shares issued from exercise of employee share options. |
+1.2% | |
| 07 May 26 | Results | Final Results and Investor Presentation
FY25 revenue increased 3% to £40.0m; underlying profit before tax up 260% to £5.0m; net debt reduced 55% to £3.2m. |
+16.2% |
|
in line expectations Group Revenue £40.0m (£38.8m)Underlying Profit Before Tax £5.0m (£1.4m)Profit Before Tax £4.4m (£(39.1)m)Net Debt £3.2m (£7.1m)Free Cash Flow £3.9m (£2.6m)Consumer Legal Services Revenue £23.8m (£22.9m)
|
|||
| 06 Mar 26 | Holding | Holding(s) in Company | |
| 06 Mar 26 | Holding | Holding(s) in Company | |
| 04 Feb 26 | Holding | Holding(s) in Company | |
| 27 Jan 26 | Trading update | Year End Trading Update
FY2025 revenues 3% ahead and underlying operating profit up 86% to £7.3m; net debt cut 55% to £10-year low. |
+1.4% |
|
in line expectations Revenue c. £40.0m (£38.8m)Underlying operating profit c. £7.3m (£3.9m)Underlying profit before tax c. £5.0m (£1.4m)Free cash flow £3.9m (£2.6m)Net debt £3.2m (£7.1m)NAL claims settled 3,197
|
|||
| 19 Dec 25 | Routine | Grant of Awards under Group Share Option Plan | |
| 24 Sep 25 | Results | Half-year Results
H1 2025 revenue flat at £19.2m, underlying operating profit up 74% to £3.2m, net debt fell to 10-year low of £5.6m. |
−3.9% |
|
in line expectations Revenue £19.2m (£19.4m)Underlying operating profit £3.2m (£1.8m)Profit before tax £1.9m (£0.5m)Basic earnings per share 3.0p (0.7p)Free cash flow £1.5m (£0.7m)Net debt £5.6m (£9.0m)
|
|||
| 15 Sep 25 | Routine | Notice of Results and Investor Presentation | |
| 19 Aug 25 | Exercise of Share Options and Total Voting Rights
25,000 share options exercised by employees at nominal value, total voting rights now 48,226,103 shares. |
−1.3% | |
| 30 Jul 25 | Exercise of Share Options and Total Voting Rights
25,000 new ordinary shares issued following exercise of employee share options. |
+11.4% | |
| 30 Jul 25 | Trading update | Half Year Trading Update
H1 2025 revenues flat at £19.2m but underlying operating profit up 67% to £3.2m; net debt reduced 21% to £5.6m. |
+11.4% |
|
in line expectations Revenue (H1 2025) £19.2m (£19.2m (H1 2024))Underlying operating profit (H1 2025) £3.2m (£1.9m (H1 2024))Free cash flow (H1 2025) £1.4m (£0.7m (H1 2024))Net debt (30 June 2025) £5.6m (£7.1m (31 December 2024))National Accident Law case settlements cash (H1 2025) £5.3m (£4.5m (H2 2024))Enquiry acquisition cost reduction (vs September 2024 peak) c. 32% lower
|
|||
| 07 Jul 25 | Holding | Holding(s) in Company | |
| 30 Jun 25 | Holding | Holding(s) in Company | |
| 30 Jun 25 | Exercise of Share Options and Total Voting Rights
168,000 new ordinary shares issued following exercise of employee share options. |
+4.0% | |
| 26 Jun 25 | Routine | Result of AGM | |
| 26 Jun 25 | AGM Statement
NAHL confirms Q1 momentum continued into Q2, reaffirms full year guidance in line with market expectations. |
+13.8% | |
|
in line expectations |
|||
| 19 Jun 25 | Cessation of sale process of Bush & Co.
Disposal process for Critical Care business Bush & Co. concluded without a sale. |
−7.8% | |
| 30 May 25 | Routine | Total Voting Rights | |
| 30 May 25 | Results | Annual Report & Accounts and Notice of AGM
NAHL Group posts Annual Report and Accounts for year ended 31 December 2024 and notices AGM for 26 June 2025. |
+3.3% |
| 30 May 25 | Holding | Holding(s) in Company | |
| 22 May 25 | Routine | Issue of Equity from Exercise of Options and TVR | |
| 20 May 25 | Routine | Issue of Equity from Exercise of Options and TVR | |
| 16 May 25 | Routine | Issue of Equity from Exercise of Options and TVR | |
| 07 May 25 | Results | Final Results and Investor Presentation
FY2024 revenue fell 8% to £38.8m; underlying operating profit £3.9m; net debt reduced 27% to £7.1m. |
+0.0% |
|
in line with market expectations expectations Group Revenue £38.8m (£42.2m)Underlying Operating Profit £3.9m (£4.1m)Net Debt £7.1m (£9.7m)Underlying Profit Before Tax £1.4m (£0.6m)NAL settlement cash collected £8.5m (£6.0m)Free Cash Flow £2.6m (£3.6m)
|
|||
| 25 Apr 25 | Routine | Issue of Equity from Exercise of Options and TVR | |
| 13 Mar 25 | Holding | Holding(s) in Company | |
| 26 Feb 25 | Holding | Holding(s) in Company | |
| 26 Feb 25 | Holding | Holding(s) in Company | |
| 24 Feb 25 | Holding | Holding(s) in Company | |
| 29 Jan 25 | Trading update | Year End Trading Update
Full-year revenues £38.8m (down 8%), PBT £0.8m (up 23%), net debt reduced to £7.1m. |
+7.0% |
|
in line expectations Revenue £38.8m (£42.2m)Underlying operating profit £3.9m (£4.4m)Profit before tax £0.8m (£0.6m)Net debt £7.1m (£9.7m)NAL new enquiries 5,892 (8,518)NAH new enquiries 19,744 (35,643)
|
|||
| 23 Dec 24 | Update on potential disposal of Bush & Co.
NAHL confirms discussions progressing with final bidders for Bush & Co. Critical Care business disposal. |
+1.5% | |
| 29 Nov 24 | Holding | Holding(s) in Company | |
| 25 Nov 24 | Holding | Holding(s) in Company | |
| 18 Nov 24 | Holding | Holding(s) in Company | |
| 24 Sep 24 | Results | Half-year Results
H1 revenue down 7% to £19.4m; operating profit flat at £1.8m; net debt reduced to £9.0m. Exploring Bush & Co sale. |
+11.2% |
|
in line with management's expectations expectations Revenue £19.4m (£21.0m)Operating profit £1.8m (£1.8m)Profit before tax £0.5m (£(0.0)m)Net debt £9.0m (£9.7m)Free cash flow £0.7m (£1.8m)Bush & Co revenue growth 11%
|
|||
| 05 Sep 24 | Routine | Notice of Results and Investor Presentation | |
| 08 Aug 24 | Trading update | Half Year Trading Update
H1 2024 revenues £19.4m, down from £21.0m; operating profit in line with prior year; net debt reduced to £9.0m. |
+4.6% |
|
in line expectations H1 2024 revenues £19.4m (£21.0m)Operating profit broadly in line with last yearNet debt £9.0m (£9.7m)
|
|||
| 27 Jun 24 | Routine | Result of AGM | |
| 27 Jun 24 | Trading update | AGM Statement and Trading Update
NAH Group flags significantly lower revenues and profits for 2024 due to higher enquiry acquisition costs and slower market recovery. |
−15.2% |
|
below expectations NAL claims settled 19% more (five months to 31 May 2024 vs 2023)NAL cash from settlements £3.3m (56% increase)NAH enquiries generated approximately 9,700 (33% fewer than equivalent period 2023)NAH marketing spend reduction 45% (Q1 2024)
|
|||
| 26 Jun 24 | Director dealing | Director/PDMR Shareholding | |
| 13 Jun 24 | Director dealing | Director/PDMR Shareholding | |
| 06 Jun 24 | Director dealing | Director/PDMR Shareholding | |
| 31 May 24 | Routine | Total Voting Rights | |
| 30 May 24 | Results | Annual Report & Accounts and Notice of AGM
Annual Report and Accounts for year ended 31 December 2023 posted; AGM scheduled for 27 June 2024. |
−2.4% |
| 22 May 24 | Holding | Holding(s) in Company | |
| 17 May 24 | Director dealing | Issue of Equity, Director/PDMR Shareholding & TVR | |
| 02 May 24 | Results | Final Results
Revenue grew 2% to £42.2m, operating profit fell 13% to £4.1m, net debt reduced 27% to £9.7m. |
+1.4% |
|
Group Revenue £42.2m (£41.4m)Operating Profit £4.1m (£4.8m)Profit Before Tax £0.65m (£0.57m)Net Debt £9.7m (£13.3m)Free Cash Flow £3.6mBasic Continuing EPS 0.9p (0.8p)
|
|||
| 30 Apr 24 | Routine | Total Voting Rights | |
| 24 Apr 24 | Routine | Issue of Equity from Share Options and TVR | |
| 23 Apr 24 | Routine | Notice of Results and Investor Presentation | |
| 05 Apr 24 | Holding | Holding(s) in Company | |
| 05 Apr 24 | Response to speculation
Board confirms investigating potential sale of Critical Care business Bush & Company Rehabilitation Limited. |
+12.7% | |
| 08 Mar 24 | Renewal of Banking Facilities
NAHL renewed banking facilities with Clydesdale Bank/Virgin Money, extending RCF maturity to December 2025 and reducing limit to £15m. |
+0.8% | |
|
RCF limit £15mRCF maturity extended to 31 December 2025Net debt £9.7m (£13.3m)Interest rate 2.25% above SONIA
|
|||
| 24 Jan 24 | Trading update | Year End Trading Update
FY2023 revenues up 2% to £42.2m, net debt reduced 27% to £9.7m ahead of expectations. |
+10.7% |
|
ahead on net debt, in line on PBT, slightly ahead on operating profit expectations Revenue £42.2m (£41.4m)Operating profit £4.1m (£4.8m)Profit before tax £0.6m (£0.6m)Net debt £9.7m (£13.3m)NAL cash from settlements £6.0m (£3.5m)Bush & Co revenue £14.6m (£13.2m)
|
|||
| 30 Oct 23 | Routine | Grant of options under SAYE Scheme | |
| 19 Oct 23 | Holding | Holding(s) in Company | |
Company filings. Not investment advice.